# clm_FA870C5AC561

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: cash_and_equivalents  
value: 2,307,600,000 United States dollar  
valid_from: 2016-03-31  
valid_to: 2016-06-30  
published: 2016-04-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_AF8251DBBE60  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company cash and equivalents: 2,307,600,000 United States dollar", as of 2016-03-31 (until 2016-06-30). Claim clm_FA870C5AC561, https://asof.is/claim/clm_FA870C5AC561, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947816000353/0000059478-16-000353-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-04-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947816000353/0000059478-16-000353-index.htm (primary, SEC EDGAR 10-Q Q1 FY2016, published 2016-04-29)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | cash_and_equivalents | 3,666,400,000 United States dollar | valid 2015-12-31 to 2016-03-31 | conf 0.95 | superseded | superseded_by [clm_FA870C5AC561](/claim/clm_FA870C5AC561.md) | [clm_87E254B2B673](/claim/clm_87E254B2B673.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.